CXCR6通过促进自然杀伤T细胞和CD4+ T细胞依赖性衰老细胞清除抑制肝癌发生
本研究在小鼠肝癌模型中评估CXCR6依赖性免疫机制在肝癌发生中的作用,发现CXCR6缺陷小鼠在DEN注射后肿瘤负荷显著高于野生型,且肝内表达肿瘤坏死因子和干扰素的恒定自然杀伤T细胞及CD4+ T细胞数量减少。NKT细胞和CD4+ T细胞通过CXCR6依赖性机制促进衰老肝细胞清除以预防肝癌发生。
要点
- CXCR6缺陷小鼠在DEN诱导后肿瘤负荷显著高于野生型小鼠。
- CXCR6缺陷小鼠肝内表达肿瘤坏死因子和干扰素的恒定NKT细胞及CD4+ T细胞数量减少。
- NKT细胞和CD4+ T细胞通过CXCR6依赖性机制促进衰老肝细胞清除以预防肝癌发生。
核心结论
- 在小鼠肝癌研究中发现CXCR6介导NKT细胞和CD4+ T细胞清除衰老肝细胞。
- 作者认为,减少肝脏CXCR6活性或减少炎症、调节免疫应答的抗纤维化策略应测试其对肝癌发生的影响。
研究设计与样本
- 研究使用C57BL/6J野生型小鼠和CXCR6缺陷小鼠(Cxcr6eGfp/eGfp)注射二乙基亚硝胺诱导肝癌,并注射α-半乳糖神经酰胺激活NKT细胞。
- 研究还在肝细胞特异性条件性删除NEMO的小鼠(NemoLPC-KO和NemoLPC-KOCxcr6eGfp/eGfp小鼠)中进行,该小鼠发生炎症相关肝肿瘤。
- 收集肝硬化患者(n=43)、肝细胞癌患者(n=35)和无上述疾病对照个体(n=25)的肝组织。
- 进行骨髓移植实验,将Cxcr6eGfp/eGfp或野生型小鼠骨髓转移至受照射C57BL/6J小鼠。
- 从CD45.1+野生型小鼠脾和肝脏分离CD4+ T细胞或NKT细胞,在DEN注射后过继转移至CXCR6缺陷小鼠。
主要发现
- DEN注射后,CXCR6缺陷小鼠肿瘤负荷显著高于野生型小鼠,肿瘤进展增加,特征为肝内表达肿瘤坏死因子和干扰素的恒定NKT细胞及CD4+ T细胞数量减少。
- NemoLPC-KOCxcr6eGfp/eGfp小鼠肝脏衰老肝细胞显著多于NemoLPC-KO小鼠。
- 骨髓嵌合体、过继细胞转移实验和NemoLPC-KO小鼠分析发现,NKT细胞和CD4+ T细胞通过需要CXCR6的过程促进衰老肝细胞清除以预防肝癌发生。
- 给野生型小鼠注射α-半乳糖神经酰胺可增加NKT细胞对衰老肝细胞的清除。
- 在人肝细胞癌中观察到CXCR6相关淋巴细胞在瘤周积聚,与肝硬化组织相比似乎减少。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Inflammation in the liver provokes fibrosis, but inflammation is also important for tumor surveillance. Inhibitors of chemokine pathways, such as CXCL16 and CXCR6 regulation of lymphocyte trafficking, are being tested as antifibrotic agents, but their effects on the development of hepatocellular carcinoma (HCC) are unclear. We assessed the roles of CXCR6-dependent immune mechanisms in hepatocarcinogenesis. METHODS: C57BL/6J wild-type (WT) mice and CXCR6-deficient mice (Cxcr6eGfp/eGfp) were given injections of diethylnitrosamine (DEN) to induce liver cancer and α-galactosylceramide to activate natural killer T (NKT) cells. We also performed studies in mice with conditional, hepatocyte-specific deletion of NEMO, which develop inflammation-associated liver tumors (NemoLPC-KO and NemoLPC-KOCxcr6eGfp/eGfp mice). We collected liver tissues from patients with cirrhosis (n = 43), HCC (n = 35), and neither of these diseases (control individuals, n = 25). Human and mouse liver tissues were analyzed by histology, immunohistochemistry, flow cytometry, RNA expression arrays (from sorted hepatic lymphocytes), and matrix-assisted laser desorption/ionization imaging. Bone marrow was transferred from Cxcr6eGfp/eGfp or WT mice to irradiated C57BL/6J mice, and spleen and liver cells were analyzed by flow cytometry. CD4+ T cells or NKT cells were isolated from the spleen and liver of CD45.1+ WT mice and transferred into CXCR6-deficient mice after DEN injection. RESULTS: After DEN injection, CXCR6-deficient mice had a significantly higher tumor burden than WT mice and increased tumor progression, characterized by reduced intrahepatic numbers of invariant NKT and CD4+ T cells that express tumor necrosis factor and interferon gamma. Livers of NemoLPC-KOCxcr6eGfp/eGfp mice had significantly more senescent hepatocytes than livers of NemoLPC-KO mice. In studies of bone-marrow chimeras, adoptive cell transfer experiments, and analyses of NemoLPC-KO mice, we found that NKT and CD4 T cells promote the removal of senescent hepatocytes to prevent hepatocarcinogenesis, and that this process required CXCR6. Injection of WT with α-galactosylceramide increased removal of senescent hepatocytes by NKT cells. We observed peritumoral accumulation of CXCR6-associated lymphocytes in human HCC, which appeared reduced compared with cirrhosis tissues. CONCLUSIONS: In studies of mice with liver tumors, we found that CXCR6 mediated NKT-cell and CD4+ T-cell removal of senescent hepatocytes. Antifibrotic strategies to reduce CXCR6 activity in liver, or to reduce inflammation or modulate the immune response, should be tested for their effects on hepatocarcinogenesis.
引用
- Mossanen JC, Kohlhepp M, Wehr A, et al. CXCR6 Inhibits Hepatocarcinogenesis by Promoting Natural Killer T- and CD4+ T-Cell-Dependent Control of Senescence. Gastroenterology. 2019. PMID: 30710528. doi:10.1053/j.gastro.2019.01.247
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。